Now Available: Inside Drug Pricing

Inside Drug Pricing is up and running. If you haven't already tried Inside Health Policy, you can sign up for a trial right now, and select Inside Drug Pricing as your included newsletter.

Inside Drug Pricing will be your one-stop shop for coverage of the heated debate about how to lower the cost of prescription drugs.

The price of drugs has been a focus for years, but President Trump's commitment to "the most sweeping action in history to lower the price of prescription drugs for the American people"  takes the issue to another level entirely.

Officials at FDA, CMS, and in Congress are all vowing to do something, but nobody knows what. That’s where Inside Drug Pricing comes in. Our highly experienced editorial team will provide a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

Inside Drug Pricing includes:

  • Exclusive daily news stories posted as they break;
  • In depth analysis of drug pricing issues from our editorial team;
  • A full-text document service, offering access to reports, statements, testimony and more;
  • News in brief – a section tracking a wide variety of developments as they occur;
  • A weekly news roundup, Inside Drug Pricing, available in print or via a PDF download; and
  • E-mail alert options to ensure you know when news is happening.

All you have to do is go here, enter your e-mail address, select one of our four newsletters to be included in your trial, and click on Submit.

We look forward to hearing from you.

The Editors

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.